Summary
To establish further the clinical significance of the CA-195 tandem immunoradiometric assay in gastrointestinal malignancies, the sera of a total of 222 subjects have been analysed and compared with assays of the “classical gastrointestinal tumour markers”, CA19-9 and carcinoembryonic antigen (CEA). CA-195 elevations above normal (>10 U/ml) were noted in 51/72 (70.8%) colorectal, 15/15 (100%) pancreatic, and in 6/12 (50%) gastric cancer patients. Whereas CA19-9 was increased (>37 U/ml) in 65%, 93%, and 42% of cases, only 54% colorectal, 45% pancreatic, and 42% gastric cancer patients had pathologically elevated serum CEA levels (>5 ng/ml). No abnormal increase of both CA-195 and CA19-9 was found in healthy volunteers, whereas 3/20 (smoking) individuals had CEA levels slightly above normal. With a 29% false-positive rate noted among 103 patients with benign gastroinestinal disorders, the specifity of CA-195 was superior to that of CA19-9 (58%) and comparable with that of CEA (31%). A significant correlation between CA-195 levels and the clinical/pathological stage of disease was noted in colorectal (P<0.01) and pancreatic cancer patients (P<0.007). Preliminary results of serial measurements of CA-195 in colorectal cancer suggest that this new marker protein, which has no cross-reactivity with CEA, may be useful as a non-invasive test for postoperative surveillance of patients to detect disease recurrence, and serve to complement (though certainly not replace) standard clinical measurements of response to chemotherapy.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- CEA:
-
carcinoembryonic antigen
References
Aabo K, Pedersen H, Kjaer M (1986) Carcinoembyronic antigen (CEA) and alkaline phosphatase in progressive colorectal cancer with special reference to patient survival. Eur J Cancer Clin Oncol 22:211–217
Abott Diagnostic Division (1982) Anticarcinoembryonic antigen 125I (goat) Abott CEA-RIA: radioimmunoassay for the detection of carcinoembryonic antigen, North Chicago, Ill, USA
Bhargava AK, Petrelli NJ, Karna A, Parshall PL, Fitzpatrick JE, Douglass HO, Herrera L, Bray K, Gaur P (1989) Serum levels of cancer-associated antigen CA-195 in gastrointestinal cancers and its comparison with CA 19-9. J Clin Lab Anal 3:370–377
Bray KR, Gaur PK, Stone MR, Leung JP (1987) A monoclonal antibody that detects a tumor associated antigen in the sera of patients with colon cancer. Fed Proc 46:1059
DelVillano BC, Brennan SC, Brock P, Bucher C, Liu V, McClure M, Rake B, Space S, Westrick B, Shoemaker H, Zurawski VR Jr (1983) Radioimmunometric assay for a monoclonal defined tumor marker CA 19-9. Clin Chem 29:549–552
Fukuta S, Magnani JL, Gaur PK, Ginsburg V (1987) Monoclonal antibody CA 195 which detects cancer-associated antigens in serum, binds to human Lea blood group antigen and to its sialylated derivate. Arch Biochem Biophys 225:214–216
Gupta MK, Arciaga R, Bukowski R, Gaur PK (1987) CA-195. A new sensitive monoclonal antibody defined tumor marker for pancreatic cancer. J Tumor Marker Oncol 2:201–206
Holyoke ED, Schein PS (1985) Tumor markers. In: Calabresi P, Schein PS, Rosenberg SA (eds) Medical Oncology. Macmillan, New York, pp 178–187
Koda JE, Grauer L, Kress B (1987) Characterization of the colon carcinoma associated antigen CA-195. Fed Proc 46:1058
Moore M, Jones DJ, Schofield PF, Harnden DG (1989) Current status of tumor markers in large bowel cancer. World J Surg 13:52–59
Scheithauer W, Kornek G, Haider K, Depisch D (1990) Amonafide in metastatic colorectal carcinoma. Eur J Cancer 26:923–924
Shani A, O'Connell MJ, Moertel CG, Schutt AJ, Silvers A, Go LVW (1978) Serial plasma carcinoembryonic antigen measurements in the management of metastatic colorectal carcinoma. Ann Intern Med 88:627–630
Sundaram SG, Manimekali S, Unni S, Goldstein PJ, Sundaram U, Bray KR, Gaur PK (1987) Evaluation of antigen CA-195 for the Detection of colon cancer. J Tumor Marker Oncol 2:315–317
Zamchek N, Kupchik HZ (1980) Summary of clinical use and limitations of the carcinoembryonic antigen assay and some meth-odological considerations. In: Rose NR, Friedman H (eds) Manual of clinical immunology, 2nd. American Society of Microbiology, Washington D.C., pp 919–935
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kornek, G., Depisch, D., Temsch, E.M. et al. Comparative analysis of cancer-associated antigen CA-195, CA19-9 and carcinoembryonic antigen in diagnosis, follow-up and monitoring of response to chemotherapy in patients with gastrointestinal cancer. J Cancer Res Clin Oncol 117, 493–496 (1991). https://doi.org/10.1007/BF01612773
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01612773